Evaluation of discrepancies between conventional and liquid-based cervical cytology

Kononova I.N., Bashmakova N.V., Vainberg E.I., Rebrikova L.N., Borisevich G.A., Martem’yanova V.V., Kuznetsova Yu.N., Shmakova N.A., Beikin Ya.B.

1) «Ural Research Institute for Maternal and Child Care» of Ministry of Healthcare of Russian Federation, Ekaterinburg, Russia; 2) Municipal Autonomous Institution «Clinical Diagnostic Center», Ekaterinburg, Russia; 3) Ministry of Health of the Sverdlovsk Region, Ekaterinburg, Russia; 4) «Kachkanar central city hospital», Kachkanar, Sverdlovsk region, Russia
4«Kachkanar central city hospital», Kachkanar, Sverdlovsk region, Russia
Aim. To investigate the agreement between cervical cytology assessed by conventional hematoxylin-eosin staining and liquid-based cervical cytology (BD SurePath™ liquid-based Pap test).
Materials and methods. The study analyzed cervical cytology diagnoses of 2426 women aged 19 to 68 (mean
34 ± 11) who sought obstetric and gynecology care between 2018 and 2019 and underwent liquid-based cervical cytology using BD SurePath™ liquid-based Pap test and cervical cytology assessed by conventional hematoxylin-eosin staining.
Results. Liquid-based cervical cytology was associated with significantly higher detection rate of cervical intraepithelial neoplasia of various grades (LSIL + HSIL) compared to conventional cervical cytology (15.13 ± 0.4% and 11.99 ± 0.2%, respectively, p = 0.016 ); it also better characterized the inflammatory process (28.7 ± 1.3% and 17.9 ± 1.2%, respectively, p = 0.042) and dysbiosis (5.7 ± 0.2% and 9.3 ± 0.3%, respectively, p = 0.015) in endocervical samples, which is necessary for an adequate diagnosis and perioperative treatment of patients to prevent the recurrence of cervical neoplasia.
Conclusion. The findings of the study suggest an advantage of liquid-based cervical cytology over conventional technique, which allows a recommendation to use liquid-based cytology as the preferable cervical screening modality.

Keywords

cervical disease
cytological screening

References

  1. Аксель Е.М., Виноградова Н.Н.. Статистика злокачественных новообразований женских репродуктивных органов. Онкогинекология. 2018; 3: 64–9.[Axel E.M., Vinogradova N.N.. Statistics of malignant neoplasms of female reproductive organs. Oncogynecology. 2018; 3: 64–9. (in Russian)]. eLIBRARY ID: 35594423
  2. Аполихина И.А. Современные возможности организованного скрининга рака шейки матки. Акушерство и гинекология. 2016; 9: 22–6. [Apolikhina I.A. Current Opportunities for Organized Cervical Cancer Screening. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2016; 9: 22–6. (in Russian)]
  3. Роговская С.И. Шейка матки, влагалище, вульва. Физиология, патология, кольпоскопия, эстетическая коррекция: руководство для практикующих врачей. M.: Status Praesens, 2014. 832 с. [Rogovskaya S.I. Cervix, vagina, vulva. Physiology, Pathology, Colposcopy, Aesthetic Correction: A Guide for Practitioners: Status praesens; 2014. 832 с. (in Russian)]
  4. Bosch F.X. Epidemiology and natural history of human papillomavirus infection and type-specific implications in cervical neoplasia. Vaccine. 2008; 24(10): 1–16. doi: 10.1016/j.vaccine.2008.05.064.
  5. Радзинский В.Е. Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии. М.:ГЭОТАР-Медиа, 2014. 516 с. [Radzinsky V.E. Guidelines for outpatient care in obstetrics and gynecology: M.: GEOTAR-Media; 2014. 516 с. (in Russian)]
  6. Обоскалова Т.А., Кононова И.Н., Севостьянова О.Ю., Берзин С.А. Эпидемиологические особенности рака шейки матки у жительниц крупного промышленного города. Уральский медицинский журнал. 2014; 4(118): 69–72. [Oboskalova T.A., Kononova I.N., Sevostyanova O.Yu., Berzin S.A. Epidemiological features of cervical cancer in residents of a large industrial city. Ural Medical Journal. 2014; 4(118):69–72. (in Russian)]
  7. Кононова И.Н., Ворошилина Е.С. Особенности местного иммунитета при цервикальных интраэпителиальных неоплазиях, ассоциированных с папилломавирусной инфекцией. Российский иммунологический журнал. 2014; 8(17)3: 809–11. [Kononova I.N., Voroshilina E.S. Features of local immunity in cervical intraepithelial neoplasias associated with papillomavirus infection. Russian immunological journal. 2014; 8(17)3: 809–811. (in Russian)]
  8. WHO/ICO Information Centre on HPV and Cancer. Russian Federation: Human Papillomavirus and Related Cancers, Fact Sheet. 2016 [www.hpvcentre.net].
  9. Полонская Н.Ю. Некрасов П.И., Роговская С.И. Повышение эффективности диагностики заболеваний шейки матки: в помощь цитологу и специалисту по кольпоскопии. Доктор.Ру. 2015; 2(12): 6–9. [Polonskaya N.Yu. Nekrasov P.I., Rogovskaya S.I. Improving the efficiency of diagnosis of cervical diseases: to help the cytologist and colposcopy specialist. Doctor.Ru. 2015; 2(12): 6–9. (in Russian)]. eLIBRARY ID: 23816273
  10. Ali A.A., Richardson D., Hill N. A retrospective study of cervical screening in women under 25 years (2005–2009). Arch Gynecol Obstet. 2013; 87; 4: 765–9. doi: 10.1007/s00404-012-2631-9
  11. Tabrizi S.N., Danielewski J. HPV DNA detection in women undergoing treatment for abnormal cytology. Abstract book, 25th international papillomavirus conference. Sweden, Malmo. J prev med hyg. 2009; 50: 131–4.
  12. Кононова И.Н., Башмакова Н.В., Обоскалова Т.А., Стародубова О.С. Заболевания шейки матки: учебное пособие для врачей. Екатеринбург; 2018. 51 с. [Kononova I.N., Bashmakova N.V., Oboskalova T.A., Starodubova O.S. Diseases of the cervix uterus: a training manual for doctors. Ekaterinburg, 2018. 51 с. (in Russian)]
  13. Singh M., Mockler D., Acalin A. Immunocytochemical colocalization of P16(ink4α) and Ki-67 predikt CIN 2/3 and AIS/adenocarcinoma. Cancer Cytopathol. 2012; 120: 26–34. doi: 10.1002/cncy.20188.
  14. Паяниди Ю.Г., Жорданиа К.И., Савостикова М.В. Рак шейки матки. Традиционные и новые подходы к проблеме. Акушерство и гинекология. 2015; 7: 7–13. [Payanidi Yu.G. Zhordania K.I., Savostikova M.V. Cervical cancer. Traditional and new approaches to the problem. Obstetrics and gynecology. 2015; 7: 7–13. (in Russian)]
  15. Прилепская В.Н., ред. Заболевания шейки матки и генитальные инфекции. М.: ГЭОТАР-Медиа, 2016. 384 с. [Prilepsky V.N., ed. Diseases of the cervix and genital infections. GEOTAR-Media, 2016. 384 с. (in Russian)]
  16. Титмушш Э., Адамс К. Шейка матки: цитологический атлас. М.: Практическая медицина. 2014. 215с. [Titmushsh E., Adams K. Cervix: cytological atlas. M.: Practical medicine. 2014.215с. (in Russin)]
  17. Радзинский В.Е., Покуль Л.В., Семятов С.М. Цитологическая диагностика заболеваний шейки матки. Возможности и перспективы (основы жидкостной цитологии): учебно-методическое пособие. М.: РУДН, 2015. 52 с. [Radzinsky V.E., Pokul L.V., Semyatov S.M. Cytological diagnosis of cervical diseases. Opportunities and prospects (basics of liquid cytology): textbook.-method. allowance. M.: RUDN, 2015. 52 с. (in Russian)]
  18. Calore E., Giaccio C., Nadal S. Prevalence of anal cytologic abnormalitiesin women with positive cervical cytology. Diagn Cytopathol. 2011; 39: 323–7. doi: 10.1002/dc.21386.
  19. Tapisiz O.L., Ertan K., Tynar J. Cytology at the time of cervical colposcopy. Eur J Gynaecol Oncol. 2013; 34(1): 36–8. PMID: 23589997
  20. Mannampallil S., Samuel M.I., Liddle O. Сervical cytology in HIV positive women: are we over screening? Oral abstracts 15World Congress for Cervical Pathology and Colposcopy. 2014; 48–9.
  21. Доброкачественные и предраковые заболевания шейки матки с позиции профилактики рака: клинические рекомендации (протоколы диагностики и ведения больных). М., 2017. 54 с. [Benign and precancerous diseases of the cervix from the perspective of cancer prevention: clinical recommendations (protocols for diagnosis and management of patients). М; 2017. 54 с. (in Russian)]
  22. Denton K.J. Liquid based cytology for cervical screening. Recent advances in histopathology. 2007. 22 p.
  23. Гусаков К.И., Назарова Н.М., Прилепская В.Н., Стародубцева Н.Л., Франкевич В.Е. Перспективы профилактики рака, ассоциированного с вирусом папилломы человека. Акушерство и гинекология. 2019. 8; 33–9. [Gusakov K.I., Nazarova N.M., Prilepskaya V.N., Starodubtseva N.L., Frankevich V.E. Prospects for the prevention of cancer associated with human papillomavirus. Obstetrics and Gynecology. 2019; (8): 33–9. (in Russian)]. doi: 10.18565/aig.2019.8.33-39
  24. Vincini G., Cabuang L. Quality assurance for hpv testing in Australia - the first two years. Abstracts free Еurogin. 2019.
  25. Malinowski D. Systematic literature review on the utility of extended genotype detection for HPV type 31: prevalence and risk for cin3 disease. Abstracts free Еurogin. 2019: 5.
  26. Nicolas A., Lameiras S., Morel A., Neuzillet C. HPV genomics and cancers. Abstracts free Еurogin. 2019: 8.
  27. Cunha A., Silva A., Costa M., Saldanha C., Peixoto M., Araújo L., Sousa C., Baptista P. Impact of HPV status knowledge on cytology revision (co-test Cohort). Abstracts free Еurogin. 2019: 22.
  28. Botha M.H., Van Der Merwe F.H., Dreyer G., Snyman L.C., Breidenthal A., Breytenbach E., Visser C. Primary HPV screening and cervical cytology in HIV-negative and HIV-positive South African women. Abstracts free Еurogin. 2019:47.
  29. Liang L.A., Schauberger G., Schriefer D., Ikenberg H., Blettner M., Klug S.J. Comparison of co-testing and primary HPV screening strategies in a population-based study of 2,627 women aged 30 years and above. Abstracts free Еurogin. 2019: 59.

Received 20.12.2019

Accepted 09.01.2020

About the Authors

Irina N. Kononova, MD, PhD, Federal State Budgetary Institution “Ural Research Institute for Maternal and Child Care” of Ministry of Healthcare of Russian Federation.Repin, 1, Еkaterinburg, Russia, 620028.
Nadezhda V. Bashmakova MD, PhD, Chief Scientific Researcher, Professor Federal State Budgetary Institution “Ural Research Institute for Maternal and Child Care” of Ministry of Healthcare of Russian Federation, Honored Doctor of the Russian Federation, Chief obstetrician-gynecologist of the Ural Federal District,  
Repin, 1, Еkaterinburg, Russia, 620028.
Ella I. Vainberg, Municipal Autonomous Institution “Clinical Diagnostic Center”, Ekaterinburg, Russia.
Larisa N. Rebrikova, Municipal Autonomous Institution “Clinical Diagnostic Center”, Ekaterinburg, Russia.
Galina A. Borisevich Chief Epidemiologist of the Ministry of Health of the Sverdlovsk Region.
Valeriya V. Martemyanova, Head physician State budgetary institution of health care of the Sverdlovsk region “Kachkanar central city hospital”, Kachkanar, Sverdlovsk region, Russia.
Jakov B. Beikin, MD, PhD, Head physician Municipal Autonomous Institution “Clinical Diagnostic Center”, Ekaterinburg, Russia.
Nadezhda A. Shmakova, obstetrician-gynecologist of the highest category, postgraduate student of FSBI “Ural Research Institute of OMM” of the Ministry of Health of Russia.
Yulia N. Kuznetsova, Head of the Women’s Consultation at the Kachkanar Central City Hospital

For citation: Kononova I.N., Bashmakova N.V., Vainberg E.I., Rebrikova L.N., Borisevich G.A., Martem’yanova V.V., Kuznetsova Yu.N., Shmakova N.A., Beikin Ya.B. Evaluation of discrepancies between conventional and liquid-based cervical cytology.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2020; 1(Suppl): 86-92.(in Russian)
https://dx.doi.org/10.18565/aig.2020.1suppl.86-92

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.